JP2018538306A5 - - Google Patents

Download PDF

Info

Publication number
JP2018538306A5
JP2018538306A5 JP2018531559A JP2018531559A JP2018538306A5 JP 2018538306 A5 JP2018538306 A5 JP 2018538306A5 JP 2018531559 A JP2018531559 A JP 2018531559A JP 2018531559 A JP2018531559 A JP 2018531559A JP 2018538306 A5 JP2018538306 A5 JP 2018538306A5
Authority
JP
Japan
Prior art keywords
methanobactin
copper
binding
use according
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018531559A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018538306A (ja
JP7123339B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/081407 external-priority patent/WO2017103094A2/en
Publication of JP2018538306A publication Critical patent/JP2018538306A/ja
Publication of JP2018538306A5 publication Critical patent/JP2018538306A5/ja
Application granted granted Critical
Publication of JP7123339B2 publication Critical patent/JP7123339B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018531559A 2015-12-18 2016-12-16 銅に関連した疾患を処置するための手段及び方法 Active JP7123339B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15201070 2015-12-18
EP15201070.8 2015-12-18
LU92979 2016-02-19
LU92979 2016-02-19
PCT/EP2016/081407 WO2017103094A2 (en) 2015-12-18 2016-12-16 Means and methods for treating copper-related diseases

Publications (3)

Publication Number Publication Date
JP2018538306A JP2018538306A (ja) 2018-12-27
JP2018538306A5 true JP2018538306A5 (enExample) 2020-01-23
JP7123339B2 JP7123339B2 (ja) 2022-08-23

Family

ID=57758583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018531559A Active JP7123339B2 (ja) 2015-12-18 2016-12-16 銅に関連した疾患を処置するための手段及び方法

Country Status (6)

Country Link
US (2) US11000568B2 (enExample)
EP (2) EP3389648A2 (enExample)
JP (1) JP7123339B2 (enExample)
CN (1) CN108472281B (enExample)
CA (1) CA3000792A1 (enExample)
WO (1) WO2017103094A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017103094A2 (en) * 2015-12-18 2017-06-22 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Means and methods for treating copper-related diseases
CN111094547B (zh) * 2017-06-14 2024-02-09 德国亥姆霍兹慕尼黑中心健康与环境研究中心(有限公司) 用于纯化源自人胚胎干细胞的内胚层和胰腺内胚层细胞的方法
CN109576226A (zh) * 2018-12-24 2019-04-05 博尔赛(上海)细胞生物技术有限公司 一种iPS细胞及其重编程方法和用途
CN109706099A (zh) * 2019-01-25 2019-05-03 黑龙江大学 同时去除低温地下水中有机磷农药和硝酸盐的假单胞菌及其应用
WO2021149824A1 (ja) * 2020-01-24 2021-07-29 アイ ピース, インコーポレイテッド 人工多能性幹細胞の作製方法
JP2022104813A (ja) 2020-12-29 2022-07-11 アイ ピース,インコーポレイテッド リプログラミング因子を導入された細胞の培養方法
US20240131112A1 (en) * 2021-02-01 2024-04-25 Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Use of methanobactin for treatment of iron-related diseases
CN116333047A (zh) * 2022-12-22 2023-06-27 四川大学华西医院 一种抗菌肽及其制备方法
WO2025110984A1 (en) * 2023-11-21 2025-05-30 Hydrogene Therapeutics, Inc. Compositions and methods for treating wilson's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004056849A2 (en) * 2002-12-19 2004-07-08 The University Of Kansas Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria
US7932052B1 (en) * 2006-07-24 2011-04-26 The Regents Of The University Of Michigan Use of methanobactin
WO2017103094A2 (en) * 2015-12-18 2017-06-22 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Means and methods for treating copper-related diseases

Similar Documents

Publication Publication Date Title
JP2018538306A5 (enExample)
MX2022010811A (es) Tratamiento de la diabetes tipo 2 u obesidad o sobrepeso con el acido 2-[(4-{6-[(4-ciano-2-fluorobencil)oxi]piridin-2-il}piperidin -1-il)metil]-1-[(2s)-oxetan-2-ilmetil]-1h-bencimidazol-6-carboxil ico o una sal farmaceutica del mismo.
PH12021551116A1 (en) Functionalized heterocycles as antiviral agents
WO2019143902A3 (en) Substituted heterocycles as antiviral agents
JP2016512202A5 (enExample)
JP2014077003A5 (enExample)
JP2016523862A5 (enExample)
JP2008195730A5 (enExample)
EA031209B9 (ru) Фармацевтический состав антитела для лечения воспалительного заболевания и способы его применения
JP2011519364A5 (enExample)
JP2011225596A5 (enExample)
JP2019515884A5 (enExample)
JP2017530953A5 (enExample)
NZ625592A (en) Compositions and methods for the treatment of hepatic diseases and disorders
MX2021003253A (es) Heterociclos funcionalizados como agentes antivirales.
JP2017529389A5 (enExample)
NZ578928A (en) Methods to increase mobility of hematopoietic stem cells by use of a lipopeptide compound and treatment of associated diseases
WO2008013630A3 (en) Calcium aluminosilicate pharmaceutical
JP2013518036A5 (enExample)
CN108472281A (zh) 用于治疗铜相关疾病的手段和方法
AU2020421571A1 (en) Compositions and methods for treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases
WO2021055425A3 (en) Functionalized heterocycles as antiviral agents
JP2013532664A5 (enExample)
JP2012504584A5 (enExample)
JP2019507786A5 (enExample)